[Early detection of leptomeningeal metastasis in patients with metastatic breast carcinoma: validation of CA 15-3 measurement in cerebrospinal fluid]

Autor: Gauchez, Anne Sophie, Pez, Emilie, Boutonnat, Jean, Bourre, Jean Cyril, Pelletier, Laurent, Payan, Raoul, Mousseau, Mireille

Publikováno v: Annales de Biologie Clinique
Annales de Biologie Clinique, 2007, 65 (6), pp.653-8
Annales de Biologie Clinique, John Libbey Eurotext, 2007, 65 (6), pp.653-8

International audience; Fifteen per cent of metastatic breast cancer will develop symptomatic leptomeningeal metastases. The introduction of trastuzumab (Herceptin) therapy has improved the response rates of survival of patients with metastatic breas

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::5b14b83a55ef3b982aa898edd322a786
https://www.hal.inserm.fr/inserm-00410501